Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 3

February 8, 2021

Given the recent roll-out of the COVID-19 vaccine across the US, InCrowd conducted its third wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and perceptions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors
  • Sample Size:
    • n = 101
      • Community Hospital, Academic Hospital, Office-based
  • Fielding Period:
    • January 21st – 22nd

InCrowd’s other COVID-19 Tracking Reports:

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.